Table 2.
Data standards for regulatory submissions of BioMeTs
| Standard name | Format | Focus |
|---|---|---|
| CDISC | Tabulation data: | Objective: regulatory submission of clinical trial data |
| − The Study Data Tabulation Model (SDTM) including (SDTMIG-MD for medical devices collected data) | Note: additional metadata collected from medical devices is required with respect to data collected from BioMeTs (e.g., the location where the device was used) (Badawy et al. [64]) | |
| − Standard Exchange for Nonclinical Data (SEND) | Geographic scope: | |
| Analysis data: | − Recommended by FDA and Japan PMDA for regulatory submissions | |
| − Analysis Data Model (ADaM) | − Preferred by China NMPA | |
| − Endorsed by EMA | ||
|
| ||
| Open mHealth | Open Mobile Health | Objective: Mobile health data interoperability standard for patient health generated data |